Related references
Note: Only part of the references are listed.Octreotide
Eva Murphy et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
A Systematic Review of the Treatment of Nausea and/or Vomiting in Cancer Unrelated to Chemotherapy or Radiation
Mellar P. Davis et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Malignant Irreversible Intestinal Obstruction: The Powerful Association of Octreotide to Corticosteroids Antiemetics, and Analgesics
Catherine Weber et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2009)
Efficacy of Granisetron in the Antiemetic Control of Nonsurgical Intestinal Obstruction in Advanced Cancer: A Phase II Clinical Trial
Albert Tuca et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Management of malignant bowel obstruction
Carla Ida Ripamonti et al.
EUROPEAN JOURNAL OF CANCER (2008)
Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction
Yasuo Shima et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Established and potential therapeutic applications of octreotide in palliative care
Eric E. Prommer
SUPPORTIVE CARE IN CANCER (2008)
Report of the clinical protocol committee: Development of randomized trials for malignant bowel obstruction
Thomas Anthony et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Medical treatment for inoperable malignant bowel obstruction: A qualitative systematic review
Sebastiano Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer
UA Matulonis et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Aggressive pharmacological treatment for reversing malignant bowel obstruction
S Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Distinguishing benign from malignant bowel obstruction in patients with malignancy: Findings at MR imaging
RN Low et al.
RADIOLOGY (2003)
When the sun can set on an unoperated bowel obstruction: Management of malignant bowel obstruction
RS Krouse et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2002)
Palliative management of malignant bowel obstruction
C Ripamonti et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer
C Ripamonti et al.
SUPPORTIVE CARE IN CANCER (2001)
Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel μ opioid receptor ligands
MP Allen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction
S Mercadante et al.
SUPPORTIVE CARE IN CANCER (2000)
Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: A prospective randomized trial
C Ripamonti et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?
G Laval et al.
PALLIATIVE MEDICINE (2000)